DNA repair gene polymorphism associated with sensitivity of lung cancer to therapy

New Guidelines to Evaluate the Response to Treatment in Solid Tumors

Patrick Therasse, Susan G. Arbuck, Elizabeth A. Eisenhauer et al. · JNCI Journal of the National Cancer Institute · 2000 · 15.7K citations

World Health Organization, Solid Tumors, Cancer Management +17

DNA Repair by ERCC1 in Non–Small-Cell Lung Cancer and Cisplatin-Based Adjuvant Chemotherapy

Ken A. Olaussen, Ariane Dunant, Pierre Fouret et al. · New England Journal of Medicine · 2006 · 1.7K citations · Full text

<i>RRM1</i> Modulated In Vitro and In Vivo Efficacy of Gemcitabine and Platinum in Non–Small-Cell Lung Cancer

Gerold Bepler, Irina Kusmartseva, Swati Sharma et al. · Journal of Clinical Oncology · 2006 · 335 citations · Full text

Enhanced cisplatin cytotoxicity by disturbing the nucleotide excision repair pathway in ovarian cancer cell lines.

Muthu Selvakumaran, Debra Pisarcik, Rudi Bao et al. · PubMed · 2003 · 316 citations

Genome Instability, Medicine, A2780 Cell Lines +12

A Xeroderma pigmentosum group D gene polymorphism predicts clinical outcome to platinum-based chemotherapy in patients with advanced colorectal cancer.

D J Park, Jan Stoehlmacher, Wei Zhang et al. · PubMed · 2001 · 300 citations

Lys751gln Polymorphism, Increased Dna Repair, Genetics +13